(Reuters) – Britain’s competition watchdog fined U.S. firm Viatris 1.5 million pounds ($1.88 million) on Friday for violating an order during its investigation into Theramex’s acquisition of European rights to two of Viatris’s women’s healthcare product ranges.
The Competition and Markets Authority (CMA) said Viatris breached regulations by failing to obtain its consent before altering key staff and by not reporting the breach.
($1 = 0.7978 pounds)
(Reporting by DhanushVignesh Babu in Bengaluru; Editing by Savio D’Souza)
Comments